Insider Trading - Koppel Adam

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
    "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
    - Peter Lynch
    What is insider trading>>
    Time period:
    Insider Trading Transactions for Koppel Adam
    Goto 0, 1, Next

    Common stock purchase or sale:
    Transaction
    Date
    Reported
    DateTime
    Company Symbol Insider
    Relationship
    Shares
    Traded
    Average
    Price
    Total
    Amount
    Shares
    Owned
    Filing
    2018-01-30
    Purchase
    2018-02-01
    7:07 pm
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    300,000 $16 $4,800,000 1,989,444
    (Indirect)
    View
    2018-06-25
    Purchase
    2018-06-26
    4:50 pm
    Aptinyx Inc. APTX Koppel Adam
    Director
    400,000 $16 $6,400,000 2,225,092
    (Indirect)
    View
    2018-07-24
    Purchase
    2018-07-26
    4:27 pm
    Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    500,000 $15 $7,500,000 2,838,968
    (Indirect)
    View
    2019-05-29
    Sale
    2019-05-31
    4:15 pm
    Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    Director
    10% Owner
    1,600,000 $12.5 $20,000,000 7,330,237
    (Indirect)
    View
    2019-09-17
    Purchase
    2019-09-19
    7:05 pm
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    150,000 $18 $2,700,000 7,281,307
    (Indirect)
    View
    2019-11-19
    Sale
    2019-11-21
    4:26 pm
    Dicerna Pharmaceuticals Inc DRNA Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,750,000 $22.03 $38,552,501 5,580,237
    (Indirect)
    View
    2019-12-04
    Sale
    2019-12-06
    5:00 pm
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    1,500,000 $24.68 $37,020,000 4,080,237
    (Indirect)
    View
    2020-01-14
    Purchase
    2020-01-16
    4:20 pm
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    3,333,333 $3 $9,999,999 5,558,425
    (Indirect)
    View
    2020-02-04
    Purchase
    2020-02-06
    4:26 pm
    Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner
    294,117 $17 $4,999,989 3,979,292
    (Indirect)
    View
    2020-07-28
    Purchase
    2020-07-28
    4:45 pm
    Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner
    400,000 $17 $6,800,000 3,241,628
    (Indirect)
    View
    2020-10-26
    Purchase
    2020-10-27
    5:07 pm
    Aptinyx Inc. APTX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    3,333,333 $3 $9,999,999 8,891,758
    (Indirect)
    View
    2020-10-27
    Purchase
    2020-10-29
    8:00 pm
    Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner
    10,000,000 $10 $100,000,000 60,300,064
    (Indirect)
    View
    2020-11-09
    Purchase
    2020-11-12
    5:54 pm
    Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner
    332,293 $10.3 $3,422,618 60,632,356
    (Indirect)
    View
    2020-12-10
    Sale
    2020-12-14
    5:35 pm
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    1,000,000 $23.4 $23,400,000 3,080,237
    (Indirect)
    View
    2021-03-09
    Sale
    2021-03-11
    4:30 pm
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,450,000 $71.5 $103,675,000 5,831,307
    (Indirect)
    View
    2021-07-19
    Purchase
    2021-07-21
    4:40 pm
    RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    100,000 $20 $2,000,000 8,434,560
    (Indirect)
    View
    2021-08-10
    Sale
    2021-08-12
    8:38 pm
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,000,000 $70.25 $70,250,000 4,831,307
    (Indirect
    Direct)
    View

    Stock options: Exercise, Award, Grant, Conversion
    Transaction
    Date
    Reported
    DateTime
    Exercisable
    Expiration
    Company Symnbol Insider
    Relationship
    Shares
    Traded
    Conversion
    Price
    Shares
    Owned
    Filing
    2018-01-30
    Exercise
    2018-02-01
    7:07 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    1,689,444 $0 1,689,444
    (Indirect)
    View
    2018-01-30
    Option Award
    2018-02-01
    7:07 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    1,223,240 $0 1,991,097
    (Indirect)
    View
    2018-01-30
    Exercise
    2018-02-01
    7:07 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    1,991,097 $0 0
    (Indirect)
    View
    2018-05-16
    Option Award
    2018-05-17
    5:10 pm
    N/A
    2028-05-16
    TREVENA INC TRVN Koppel Adam
    Director
    30,000 $0 30,000
    (Direct)
    View
    2018-06-21
    Option Award
    2018-06-25
    4:19 pm
    N/A
    2028-06-21
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    10% Owner
    25,000 $0 25,000
    (Direct)
    View
    2018-06-25
    Conversion
    2018-06-26
    4:50 pm
    N/A
    N/A
    Aptinyx Inc. APTX Koppel Adam
    Director
    1,825,092 $0 1,825,092
    (Indirect)
    View
    2018-06-25
    Conversion
    2018-06-26
    4:50 pm
    N/A
    N/A
    Aptinyx Inc. APTX Koppel Adam
    Director
    50,347,396 $0 0
    (Indirect)
    View
    2018-07-24
    Conversion
    2018-07-26
    4:27 pm
    N/A
    N/A
    Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    2,338,968 $0 2,338,968
    (Indirect)
    View
    2018-07-24
    Conversion
    2018-07-26
    4:27 pm
    N/A
    N/A
    Replimune Group Inc. REPL Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    235,146 $0 0
    (Indirect)
    View
    2018-07-25
    Option Award
    2018-07-27
    4:36 pm
    N/A
    2028-07-25
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    1,835 $0 1,835
    (Direct)
    View
    2018-12-13
    Option Award
    2018-12-17
    4:46 pm
    N/A
    2028-12-13
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    8,165 $0 8,165
    (Direct)
    View
    2019-05-15
    Option Award
    2019-05-17
    5:29 pm
    N/A
    2029-05-14
    Aptinyx Inc. APTX Koppel Adam
    Director
    40,000 $0 40,000
    (Direct)
    View
    2019-06-13
    Option Award
    2019-06-17
    4:26 pm
    N/A
    2029-06-13
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    10,000 $0 10,000
    (Direct)
    View
    2019-06-20
    Option Award
    2019-06-21
    8:02 pm
    N/A
    2029-06-20
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    10% Owner
    25,000 $0 25,000
    (Direct)
    View
    2019-07-30
    Option Award
    2019-07-30
    4:37 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    1,881,720 $4.65 3,871,164
    (Indirect)
    View
    2019-09-17
    Conversion
    2019-09-19
    7:05 pm
    N/A
    N/A
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    6,078,103 $0 6,078,103
    (Indirect)
    View
    2019-09-17
    Conversion
    2019-09-19
    7:05 pm
    N/A
    N/A
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,053,204 $0 7,131,307
    (Indirect)
    View
    2019-09-17
    Conversion
    2019-09-19
    7:05 pm
    N/A
    N/A
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    6,078,103 $0 0
    (Indirect)
    View
    2019-09-17
    Conversion
    2019-09-19
    7:05 pm
    N/A
    N/A
    SpringWorks Therapeutics Inc. SWTX Bain Capital Life Sciences Investors LLC
    BC SW LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,053,204 $0 0
    (Indirect)
    View
    2020-02-04
    Conversion
    2020-02-06
    4:26 pm
    N/A
    N/A
    Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner
    2,825,602 $0 2,825,602
    (Indirect)
    View
    2020-02-04
    Conversion
    2020-02-06
    4:26 pm
    N/A
    N/A
    Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner
    859,573 $0 3,685,175
    (Indirect)
    View
    2020-02-04
    Conversion
    2020-02-06
    4:26 pm
    N/A
    N/A
    Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner
    2,825,602 $0 0
    (Indirect)
    View
    2020-02-04
    Conversion
    2020-02-06
    4:26 pm
    N/A
    N/A
    Arcutis Biotherapeutics Inc. ARQT Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Schwartz Jeffrey Lawrence
    10% Owner
    859,573 $0 0
    (Indirect)
    View
    2020-03-31
    Option Award
    2020-04-02
    4:58 pm
    N/A
    2030-03-30
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    8,296 $1.356 8,296
    (Direct)
    View
    2020-05-20
    Option Award
    2020-05-22
    4:15 pm
    N/A
    2030-05-19
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    40,000 $0 40,000
    (Direct)
    View
    2020-06-15
    Option Award
    2020-06-16
    8:09 pm
    N/A
    N/A
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    3,333 $0 3,333
    (Direct)
    View
    2020-06-15
    Option Award
    2020-06-16
    8:09 pm
    N/A
    2030-06-14
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    15,000 $0 15,000
    (Direct)
    View
    2020-06-16
    Option Award
    2020-06-18
    5:00 pm
    N/A
    2030-06-16
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    30,000 $0 30,000
    (Direct)
    View
    2020-06-16
    Option Award
    2020-06-18
    5:00 pm
    N/A
    2030-06-16
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    10,000 $0 10,000
    (Direct)
    View
    2020-06-30
    Option Award
    2020-07-02
    4:06 pm
    N/A
    2030-06-29
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    4,370 $2.677 4,370
    (Direct)
    View
    2020-07-28
    Conversion
    2020-07-28
    4:45 pm
    N/A
    N/A
    Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner
    2,522,385 $0 2,522,385
    (Indirect)
    View
    2020-07-28
    Conversion
    2020-07-28
    4:45 pm
    N/A
    N/A
    Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner
    319,243 $0 2,841,628
    (Indirect)
    View
    2020-07-28
    Conversion
    2020-07-28
    4:45 pm
    N/A
    N/A
    Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner
    22,222,220 $0 0
    (Indirect)
    View
    2020-07-28
    Conversion
    2020-07-28
    4:45 pm
    N/A
    N/A
    Annexon Inc. ANNX Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Koppel Adam
    Bain Capital Life Sciences Partners LP
    Schwartz Jeffrey Lawrence
    10% Owner
    2,812,543 $0 0
    (Indirect)
    View
    2020-09-30
    Option Award
    2020-10-02
    4:15 pm
    N/A
    2030-09-29
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    5,663 $2.163 5,663
    (Direct)
    View
    2020-10-26
    Option Award
    2020-10-26
    4:30 pm
    N/A
    N/A
    BCLS Acquisition Corp. BLSA Koppel Adam
    Director
    10% Owner
    487,500 $10 487,500
    (Indirect)
    View
    2020-10-27
    Other
    2020-10-29
    8:00 pm
    N/A
    N/A
    Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner
    49,961,944 $0 50,300,064
    (Indirect)
    View
    2020-12-10
    Option Award
    2020-12-11
    4:30 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    3,189,189 $3.7 7,060,353
    (Indirect)
    View
    2020-12-31
    Option Award
    2021-01-05
    4:44 pm
    N/A
    2030-12-30
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    5,508 $2.224 5,508
    (Direct)
    View
    2021-03-23
    Option Award
    2021-03-25
    4:30 pm
    N/A
    N/A
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    869,565 $5.75 7,929,918
    (Indirect)
    View
    2021-05-27
    Option Award
    2021-06-01
    4:30 pm
    N/A
    2031-05-26
    Aptinyx Inc. APTX Koppel Adam
    Director
    10% Owner
    40,000 $0 40,000
    (Direct)
    View
    2021-06-03
    Exercise
    2021-06-07
    6:50 pm
    N/A
    N/A
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    3,333 $0 3,333
    (Direct)
    View
    2021-06-03
    Exercise
    2021-06-07
    6:50 pm
    N/A
    N/A
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    3,333 $0 0
    (Direct)
    View
    2021-06-03
    Option Award
    2021-06-07
    6:50 pm
    N/A
    N/A
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    3,333 $0 3,333
    (Direct)
    View
    2021-06-03
    Option Award
    2021-06-07
    6:50 pm
    N/A
    2031-06-02
    Dicerna Pharmaceuticals Inc DRNA Koppel Adam
    Director
    15,000 $0 15,000
    (Direct)
    View
    2021-06-10
    Option Award
    2021-06-14
    8:25 pm
    N/A
    2031-06-10
    Cerevel Therapeutics Holdings Inc. CERE Koppel Adam
    Director
    10% Owner
    42,950 $0 42,950
    (Direct)
    View
    2021-06-16
    Option Award
    2021-06-21
    5:15 pm
    N/A
    2031-06-16
    Solid Biosciences Inc. SLDB Koppel Adam
    Director
    30,000 $0 30,000
    (Direct)
    View
    2021-07-13
    Option Award
    2021-07-14
    4:53 pm
    2022-07-13
    2031-07-12
    Foghorn Therapeutics Inc. FHTX Koppel Adam
    Director
    12,530 $0 12,530
    (Direct)
    View
    2021-07-19
    Conversion
    2021-07-21
    4:40 pm
    N/A
    N/A
    RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    6,999,998 $0 6,999,998
    (Indirect)
    View
    2021-07-19
    Conversion
    2021-07-21
    4:40 pm
    N/A
    N/A
    RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    1,334,562 $0 8,334,560
    (Indirect)
    View
    2021-07-19
    Conversion
    2021-07-21
    4:40 pm
    N/A
    N/A
    RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    35,000,000 $0 0
    (Indirect)
    View
    2021-07-19
    Conversion
    2021-07-21
    4:40 pm
    N/A
    N/A
    RAPID MICRO BIOSYSTEMS Inc RPID Bain Capital Life Sciences Investors LLC
    Bain Capital Life Sciences Partners LP
    Bain Capital Life Sciences Fund L.P.
    BCIP Life Sciences Associates LP
    Schwartz Jeffrey Lawrence
    Koppel Adam
    10% Owner
    6,672,819 $0 0
    (Indirect)
    View
    Goto 0, 1, Next